{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:28:45Z","timestamp":1794360525339,"version":"4.9.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Government of Beijing Municipality"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-68243-w","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T23:56:23Z","timestamp":1767657383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Retrospective cohort study of hepatitis B immunization strategy effects in Beijing across 30 years"],"prefix":"10.1038","volume":"17","author":[{"given":"Huai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4519-2790","authenticated-orcid":false,"given":"Weixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2061-0861","authenticated-orcid":false,"given":"Pei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianli","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-0827","authenticated-orcid":false,"given":"Qing-Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luodan","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"68243_CR1","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries, <https:\/\/www.who.int\/publications\/i\/item\/9789240091672> (2024)."},{"key":"68243_CR2","doi-asserted-by":"publisher","first-page":"S343","DOI":"10.1093\/infdis\/jiaa668","volume":"224","author":"J Pattyn","year":"2021","unstructured":"Pattyn, J., Hendrickx, G., Vorsters, A. & Van Damme, P. Hepatitis B Vaccines. J. Infect. Dis. 224, S343\u2013S351 (2021).","journal-title":"J. Infect. Dis."},{"key":"68243_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.vaccine.2017.07.046","volume":"37","author":"World Health Organization","year":"2019","unstructured":"World Health Organization Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. Vaccine 37, 223\u2013225 (2019).","journal-title":"Vaccine"},{"key":"68243_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0140-6736(99)07239-6","volume":"355","author":"European Consensus Group on Hepatitis B Immunity","year":"2000","unstructured":"European Consensus Group on Hepatitis B Immunity Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 355, 561\u2013565 (2000).","journal-title":"Lancet"},{"key":"68243_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/jiv748","volume":"214","author":"MG Bruce","year":"2016","unstructured":"Bruce, M. G. et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J. Infect. Dis. 214, 16\u201322 (2016).","journal-title":"J. Infect. Dis."},{"key":"68243_CR6","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1086\/606119","volume":"200","author":"BJ McMahon","year":"2009","unstructured":"McMahon, B. J. et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J. Infect. Dis. 200, 1390\u20131396 (2009).","journal-title":"J. Infect. Dis."},{"key":"68243_CR7","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.vaccine.2011.12.106","volume":"30","author":"SS Chaves","year":"2012","unstructured":"Chaves, S. S. et al. Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine 30, 1644\u20131649 (2012).","journal-title":"Vaccine"},{"key":"68243_CR8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/hep.20490","volume":"40","author":"CY Lu","year":"2004","unstructured":"Lu, C. Y. et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 40, 1415\u20131420 (2004).","journal-title":"Hepatology"},{"key":"68243_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30512-8","volume":"8","author":"S Mahmood","year":"2018","unstructured":"Mahmood, S., Shah, K. U. & Khan, T. M. Immune persistence after infant Hepatitis-B vaccination: a systematic review and meta-analysis. Sci. Rep. 8, 12550 (2018).","journal-title":"Sci. Rep."},{"key":"68243_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1056\/NEJMoa1007644","volume":"364","author":"SL Stramer","year":"2011","unstructured":"Stramer, S. L. et al. Nucleic acid testing to detect HBV infection in blood donors. N. Engl. J. Med. 364, 236\u2013247 (2011).","journal-title":"N. Engl. J. Med."},{"key":"68243_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jhep.2012.04.021","volume":"57","author":"S Shahmoradi","year":"2012","unstructured":"Shahmoradi, S. et al. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J. Hepatol. 57, 515\u2013521 (2012).","journal-title":"J. Hepatol."},{"key":"68243_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/hep.25988","volume":"57","author":"TW Wu","year":"2013","unstructured":"Wu, T. W., Lin, H. H. & Wang, L. Y. Chronic hepatitis B infection in adolescents who received primary infantile vaccination. Hepatology 57, 37\u201345 (2013).","journal-title":"Hepatology"},{"key":"68243_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.gastro.2011.12.035","volume":"142","author":"HL Chen","year":"2012","unstructured":"Chen, H. L. et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 142, 773\u2013781.e772 (2012).","journal-title":"Gastroenterology"},{"key":"68243_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75338-5","volume":"10","author":"N Miao","year":"2020","unstructured":"Miao, N., Zheng, H., Sun, X., Zhang, G. & Wang, F. Protective effect of vaccinating infants with a 5 microg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China. Sci. Rep. 10, 18155 (2020).","journal-title":"Sci. Rep."},{"key":"68243_CR15","doi-asserted-by":"publisher","first-page":"896","DOI":"10.4161\/hv.19989","volume":"8","author":"Y Poovorawan","year":"2012","unstructured":"Poovorawan, Y. et al. Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers. Hum. Vaccin Immunother. 8, 896\u2013904 (2012).","journal-title":"Hum. Vaccin Immunother."},{"key":"68243_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/vim.2008.0087","volume":"22","author":"T Chinchai","year":"2009","unstructured":"Chinchai, T. et al. Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization. Viral Immunol. 22, 125\u2013130 (2009).","journal-title":"Viral Immunol."},{"key":"68243_CR17","first-page":"661","volume":"11","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Booster vaccination in infancy reduces the incidence of occult HBV infection in maternal HBsAg-positive children. J. Clin. Transl. Hepatol. 11, 661\u2013669 (2023).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"68243_CR18","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.vaccine.2016.12.062","volume":"35","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults. Vaccine 35, 1064\u20131070 (2017).","journal-title":"Vaccine"},{"key":"68243_CR19","volume":"51","author":"H Zheng","year":"2024","unstructured":"Zheng, H. et al. New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020. Lancet Reg. Health West Pac. 51, 101193 (2024).","journal-title":"Lancet Reg. Health West Pac."},{"key":"68243_CR20","first-page":"658","volume":"37","author":"P Gao","year":"2016","unstructured":"Gao, P. et al. A sero-epidemiological study of hepatitis B among general population in Beijing. Chin. J. Epidemiol. 37, 658\u2013662 (2016).","journal-title":"Chin. J. Epidemiol."},{"key":"68243_CR21","doi-asserted-by":"crossref","unstructured":"Boccalini, S. et al. The First 30 Years of the Universal Hepatitis-B Vaccination-Program in Italy: A Health Strategy with a Relevant and Favorable Economic-Profile. Int. J. Environ. Res. Public Health 19, 16365 (2022).","DOI":"10.3390\/ijerph192316365"},{"key":"68243_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215652","volume":"536","author":"M Cao","year":"2022","unstructured":"Cao, M. et al. Long term outcome of prevention of liver cancer by hepatitis B vaccine: Results from an RCT with 37 years. Cancer Lett. 536, 215652 (2022).","journal-title":"Cancer Lett."},{"key":"68243_CR23","doi-asserted-by":"publisher","first-page":"e2022388","DOI":"10.1001\/jamanetworkopen.2020.22388","volume":"3","author":"MH Le","year":"2020","unstructured":"Le, M. H. et al. Prevalence of Hepatitis B vaccination coverage and serologic evidence of immunity among US-Born children and adolescents from 1999 to 2016. JAMA Netw. Open 3, e2022388 (2020).","journal-title":"JAMA Netw. Open"},{"key":"68243_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bjid.2019.10.001","volume":"23","author":"M Moghadami","year":"2019","unstructured":"Moghadami, M., Dadashpour, N., Mokhtari, A. M., Ebrahimi, M. & Mirahmadizadeh, A. The effectiveness of the national hepatitis B vaccination program 25 years after its introduction in Iran: a historical cohort study. Braz. J. Infect. Dis. 23, 419\u2013426 (2019).","journal-title":"Braz. J. Infect. Dis."},{"key":"68243_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/cid\/ciu867","volume":"60","author":"N Gara","year":"2015","unstructured":"Gara, N. et al. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults. Clin. Infect. Dis. 60, 505\u2013513 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"68243_CR26","doi-asserted-by":"publisher","first-page":"e1001774","DOI":"10.1371\/journal.pmed.1001774","volume":"11","author":"C Qu","year":"2014","unstructured":"Qu, C. et al. Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial. PLoS Med. 11, e1001774 (2014).","journal-title":"PLoS Med."},{"key":"68243_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijid.2018.08.024","volume":"78","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China. Int. J. Infect. Dis. 78, 130\u2013139 (2019).","journal-title":"Int. J. Infect. Dis."},{"key":"68243_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/14760584.2023.2289566","volume":"23","author":"J Qiu","year":"2024","unstructured":"Qiu, J. et al. Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses. Expert Rev. Vaccines 23, 69\u201381 (2024).","journal-title":"Expert Rev. Vaccines"},{"key":"68243_CR29","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/hep.32265","volume":"75","author":"WQ He","year":"2022","unstructured":"He, W. Q., Guo, G. N. & Li, C. The impact of hepatitis B vaccination in the United States, 1999-2018. Hepatology 75, 1566\u20131578 (2022).","journal-title":"Hepatology"},{"key":"68243_CR30","first-page":"555","volume":"28","author":"J Wu","year":"2007","unstructured":"Wu, J. et al. A sero-epidemiological study on hepatitis B among general population in Beijing. Chin. J. Epidemiol. 28, 555\u2013557 (2007).","journal-title":"Chin. J. Epidemiol."},{"key":"68243_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ije\/dyac207","volume":"52","author":"CP Farrington","year":"2023","unstructured":"Farrington, C. P. Estimation of vaccine effectiveness using the screening method. Int. J. Epidemiol. 52, 14\u201321 (2023).","journal-title":"Int. J. Epidemiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68243-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68243-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68243-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T03:03:48Z","timestamp":1770779028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68243-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68243"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-68243-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1523"}}